Atul Ltd 2017-18

173 The Group has carried out annual Goodwill impairment assessment as at March 31, 2018. The Management believes that any reasonably possible change in the key assumptions may not cause the carrying amount to exceed the recoverable amount of the cash generating units. Accordingly, there was no impairment recorded during the year. Note 4 (b) Biological assets a) Biological assets of the Group consists: i) Immature tissue culture raised date palms that are classified as non-current biological assets. The Group has a plucking cycle of about 4-5 months. ii) Mature tissue culture raised date palms that are classified as current biological assets. b) Reconciliation of changes to the carrying value of biological assets between the beginning and the end of the current year are as follows: ( ` cr) Particulars Tissue culture raised date palms March 31, 2018 March 31, 2017 Mature Immature Mature Immature Opening balance 11.77 9.32 8.28 11.25 Increase due to production 0.18 9.86 0.22 9.40 Change due to biological transformation 7.68 (7.68) 11.33 (11.33) Decrease due to sale (9.04) – (9.84) – Decrease due to write off (0.05) – – – Change in fair value due to price changes 0.66 – 1.78 – Closing balance 11.20 11.50 11.77 9.32 Current assets 11.20 – 11.77 – Non-current assets* – 11.50 – 9.32 Biological assets shown in Balance Sheet 11.20 11.50 11.77 9.32 *  Non-current biological assets are expected to take more than 12 months from reporting date to become ready for dispatch. As at March 31, 2018, the Group had 3,658 mature plants (March 31, 2017: 14,535) and 55,916 immature plants (March 31, 2017: 30,897). During current year the Group has sold 10,723 plants (March 31, 2017: 1,986). ( ` cr) Note 5 Investments accounted for using the equity method Place of business % of ownership interest As at March 31, 2018 As at March 31, 2017 Investment in equity instruments (fully paid-up) Unquoted investment in joint venture company: Rudolf Atul Chemicals Ltd India 50 10.00 14.31 Add: Group share of profit | (loss) for the year 0.72 (4.31) Total equity accounted investments 10.72 10.00 ( ` cr) Particulars Book value as at Market value as at March 31, 2018 March 31, 2017 March 31, 2018 March 31, 2017 Quoted – – – – Unquoted 10.72 10.00 – – 10.72 10.00 – – Notes to the Consolidated Financial Statements